Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) January
May 4, 2024
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
Research and development $ 239,199 $ 745,461 $ 745,461 -
General and administrative 3,946,510 1,953,780 12,018,878 3,639,992
Total operating expenses (3,946,510) (1,953,780) (12,018,878) (3,639,992)
Operation Expension
Research and development $ 239,199 $ 745,461 $ 745,461 $ 745,461
General and administrative 3,946,510 1,953,780 12,018,878 3,639,992

source

10-Q

XBRL